DBT
ALXN

Dubuque Bank & Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Dubuque Bank & Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,323
Closed -$243K – 288
2021
Q2 		$243K Sell
1,323
-90
-6% -$15.4K 0.03% 231
2021
Q1 		$216K Hold
1,413
– – 0.02% 247
2020
Q4 		$221K Buy
+1,413
New +$182K 0.03% 235
2019
Q2 		– Sell
-50
Closed -$7K – 664
2019
Q1 		$7K Buy
+50
New +$6.22K ﹤0.01% 538
2017
Q2 		– Sell
-138
Closed -$17K – 673
2017
Q1 		$17K Hold
138
– – ﹤0.01% 442
2016
Q4 		$17K Hold
138
– – ﹤0.01% 363
2016
Q3 		$17K Buy
138
+59
+75% +$7.59K ﹤0.01% 342
2016
Q2 		$9K Sell
79
-59
-43% -$8.37K ﹤0.01% 447
2016
Q1 		$19K Buy
138
+46
+50% +$6.75K ﹤0.01% 349
2015
Q4 		$18K Buy
+92
New +$16.1K ﹤0.01% 410

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Dubuque Bank & Trust's ALXN Position: Q3 2021 in Review

Dubuque Bank & Trust sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,323 shares — an estimated $243K sold.

Dubuque Bank & Trust first reported a position in ALXN in Q4 2015 and held it in 10 quarters. The position peaked at $243K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Dubuque Bank & Trust reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Dubuque Bank & Trust sold 1,323 Alexion Pharmaceuticals shares in Q3 2021, an estimated $243K.
  • Dubuque Bank & Trust first reported a position in Alexion Pharmaceuticals in Q4 2015 and held it in 10 quarters.
  • Dubuque Bank & Trust's Alexion Pharmaceuticals position peaked at $243K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Dubuque Bank & Trust's 13F filing for Q3 2021, filed 9 Nov 2021.